Optinova today announces a series of investments that have been approved by Group Management and the Board of Directors to significantly increase our production capacity globally. These investments are part of our long-term growth strategy and reinforces our commitment to serving customers better and supporting the local communities where we operate.
In the first half of 2022, the Optinova Group has approved investments to expand our capacity in all four manufacturing sites in Finland, Thailand and the US. Besides additional extrusion lines, more floorspace will be added, together with new supporting facilities at Optinova Innovation Center.
“The new investments reflect our increased engagement with existing customers and an influx of orders from new partners across industries,” says Allan Boye, CCO, Optinova Group. “The added capacity will enable us to meet the heightened market demand and improve our production efficiency by employing the latest extrusion technology and automation systems in the new facilities.”
The approved investments cover a number of aspects from construction work to sustainable innovation and clean energy.
Optinova Group | +358 18 32 900 | email@example.com | optinova.com/newsroom
Follow us on social media: @OptinovaGroup
Founded in 1971, Optinova is a world-leading extrusion partner for advanced medical and industrial tubing solutions. With global sales offices and four extrusion plants in Finland, Thailand, and the US, we are serving over 1 000 customers across industries.
We take pride in being the top-of-mind thermoplastics and fluoropolymers extrusion partner of over 1 000 customers ever since 1971.
From IV tubing to medical-grade heat shrink, we provide customers with the broadest, most versatile tubing solutions for different medical applications.
Optinova offers the most customizable PTFE, FEP, PFA, ETFE, PVdF, MFA and PEEK tubing, available in virtually any size and profile, with deliveries available across the globe.